We always puts patients first. Our goal is to improve their treatment options and find a cure.

with the Cholangiocarcinoma Foundation, you are not alone in your bile duct cancer diagnosis

We lead collaborative efforts, bringing scientists, clinicians, and healthcare providers together to share research, resources, and funding.


We urgently improve methodologies, technologies, and partnerships to energize and drive our programs, research, and funding strategies.


We provide vital resources, education, and support to cholangiocarcinoma patients and their families.


Since 2015, the Foundation has awarded more than $1.9 million in funding for innovative, high-quality research. In accordance with the Foundation’s Research Philosophy, CCF supports promising projects that are less likely to get traditional funding. Open-access research that catalyzes collaboration and focuses on finding a cure is a core value of the program.

A global collaboration of research groups from renowned institutions that are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment and prognosis .

Facilitates multi-center basic, translational, and clinical research to ensure rapid translation from bench to bedside.

The ICPR is a global collaborative effort to connect our patient community and researchers who need to expand their knowledge of cholangiocarcinoma (bile duct cancer). It is the only registry of patient health information related solely to cholangiocarcinoma. It accelerates research for early detection, diagnosis, new treatments and ultimately a cure for cholangiocarcinoma.

CCF’s Annual Conference is unique; not only does it bring the clinical, medical and research communities together, but it includes patients and caregivers. CCF believes that those living with cholangiocarcinoma have a direct stake in their own medical care and are in a unique position to provide input. CCF’s conference programming addresses questions and concerns that are important to patients and their families.

Patients and caregivers—having experienced the disease firsthand—are invited to learn about cholangiocarcinoma, share their personal experiences, and contribute to future efforts to further cholangiocarcinoma research. Patients are central to all CCF efforts.